2BB score and signals
Cocrystal Pharma, Inc.’s current 2BB score is 28 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 8 | Very Low |
| Momentum | 44 | Stable |
| Financial strength | 25 | Weak |
| Quality | 20 | Weak |
| Risk | 49 | Moderate |
Company facts
| Headquarters | Bothell, Washington, United States |
| Founded | 2006 |
| Employees | 10 |
| 52-week range | $0.76 – $2.67 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-12 | — | -0.153 | — | $0.00 |
| 2026-08-17 | — | -0.1683 | — | $0.00 |
| 2026-05-15 | -0.17 | -0.153 | $225,000.00 | $0.00 |
| 2026-03-09 | -0.17 | -0.1785 | $0.00 | $0.00 |
Related companies
